Cancer Incidence and Incidence Rates in Japan in 1992-93: Estimates Based on Data from Seven Population-based Cancer Registries Acknowledgments References Cancer Incidence and Incidence Rates in Japan in 1992-93: Estimates Based on Data from Seven Population-based Cancer Registries
Cancer Incidence and Incidence Rates in Japan in 1992-93: Estimates Based on Data from Seven Population-based Cancer Registries
The Research Group for Population-based Cancer Registration in Japan*
Key words: cancer incidence - incidence estimates - cancer registry - Japan
The Research Group for Population-based Cancer Registration in Japan estimated cancer incidence in Japan in 1992 and 1993 based on data from seven population-based cancer registries: Yamagata, Chiba, Kanagawa (for 1993 only), Fukui, Osaka, Tottori (for 1992 only), Hiroshima City and Nagasaki. The method of estimation and its limitations are explained in Refs 1 and 2. The number of incidences, crude rates, age-standardized rates and completeness of registration in 1992 are shown in Table 1 and the age-specific number of incidences and the rates are shown in Tables 2 and 3 according to sex and primary site. The corresponding data in 1993 are shown in Tables 4-6. The number of incidences for 1993 was estimated as 430 300. The time trends of age-standardized incidence rates for major sites in 1975-1993 standardized to the world population are shown in Fig. 1 and those standardized to the 1985 Japanese model population are shown in Fig. 2. The leading site in the age-standardized incidence rate for female is the breast in Fig. 1 compared with the stomach in Fig. 2.
Figure1. Trends of age-standardized cancer incidence rates for major sites (standard population: world population).
Figure2. Trends of age-standardized cancer incidence rates for major sites (standard population: 1985 Japanese model population).
Estimated cancer incidence data in Japan by sex, site, five-year age-group and calendar year during the period of 1975-1993 are now available on a Web site (http://www.iph.pref.osaka.jp/omc/ocr/) or by correspondence with the principal investigator of the Research Group (Dr A. Oshima).
In 1996-1997 the Research Group conducted the 23rd-24th survey on cancer incidence and cancer medical care with the cooperation of the Aichi Cancer Center (Dr T. Kuroishi) and 13 cancer registries: Miyagi (Dr S. Hisamichi), Yamagata (Dr T. Matsuda), Chiba (Dr M. Murata), Kanagawa (Dr N. Okamoto), Fukui (Dr M. Fujita), Aichi (Dr K. Inuzuka), Osaka (Dr A. Oshima), Hyogo (Dr T. Ishida), Tottori (Dr A. Suyama), Hiroshima City (Dr K. Mabuchi), Nagasaki (Drs T. Ikeda and M. Soda), Saga (Dr M. Mori) and Okinawa (Dr T. Uehara). The study was supported by a Grant-in-Aid for cancer research from the Japanese Ministry of Health and Welfare (8-2).
1. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1988: estimates based on data from ten population-based cancer registries. Jpn J Clin Oncol 1994;24:299-304
2. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985-89: re-estimation based on data from eight population-based cancer registries. Jpn J Clin Oncol 1998;28:54-67.
Incidence, completeness of reporting and accuracy of diagnosis in Japan according to sex and primary site, 1992
Sex
Primary sites
ICD-9th
No. of incidences
Crude rate*
Age-standardized rate*
Completeness of reporting
Accuracy of diagnosis
World population
Japanese 1985 model population
DCO/I (%)
I/D
HV/I (%)
Male
All sites
140-208
243 595
416.3
267.0
373.6
15.9
1.74
67.3
Lip, oral cavity, pharynx
140-149
4 355
7.3
4.9
6.6
9.5
2.01
83.9
Esophagus
150
8976
15.3
9.8
13.6
12.3
1.37
77.5
Stomach
151
66 840
115.8
73.0
102.2
10.4
2.19
83.6
Colon
153
27 395
46.0
30.0
41.7
8.7
3.11
82.5
Rectum
154
15 801
27.2
17.4
23.9
8.2
2.57
85.5
Liver
155
24 184
39.8
26.8
36.1
25.7
1.28
25.9
Gallbladder
156
6309
11.1
6.6
9.8
23.4
1.12
41.7
Pancreas
157
8155
14.3
8.7
12.5
27.8
1.04
30.1
Larynx
161
3216
5.4
3.5
4.9
5.3
4.01
88.7
Lung
162
34 874
60.3
36.8
54.0
24.3
1.19
51.7
Skin
172, 173
3086
5.2
3.3
4.8
4.6
8.14
88.1
Prostate
185
9138
15.9
9.1
14.5
17.0
2.24
70.0
Bladder
188
7277
12.4
7.7
11.3
10.7
3.34
80.9
Kidney
189
4931
8.3
5.5
7.5
13.7
2.27
67.4
Brain and nervous system
191-192
1926
3.3
2.5
3.1
20.8
2.68
63.2
Thyroid
193
1010
1.7
1.2
1.5
8.3
3.23
83.5
Malignant lymphoma
200-202
5307
9.0
6.1
8.2
20.1
1.58
72.1
Multiple myeloma
203
1354
2.3
1.4
2.1
36.5
1.17
43.7
Hematopoietic tissue
204-208
3454
5.7
4.7
5.5
29.7
1.03
49.2
Female
All sites (incl. CIS)
140-208, 233
186 085
305.6
172.0
232.4
14.6
2.02
70.5
All sites
140-208
180 464
296.8
164.8
223.6
14.9
1.96
69.8
Lip, oral cavity, pharynx
140-149
2019
3.3
1.8
2.5
9.3
2.45
79.5
Esophagus
150
1963
3.2
1.5
2.2
16.1
1.51
72.0
Stomach
151
35 467
59.8
30.6
42.7
12.1
2.02
81.3
Colon
153
21 116
34.8
18.0
25.2
10.9
2.46
79.0
Rectum
154
10 355
17.3
9.1
12.6
9.4
2.63
82.1
Liver
155
8890
14.4
7.4
10.3
27.8
1.30
25.4
Gallbladder
156
8024
13.8
5.9
8.8
27.5
1.10
36.9
Pancreas
157
6508
11.0
4.9
7.3
31.1
1.03
24.8
Larynx
161
218
0.4
0.2
0.2
15.7
2.75
77.2
Lung
162
12 925
21.4
10.3
14.8
25.5
1.18
49.4
Skin
172 173
2954
4.9
2.4
3.3
5.3
8.64
87.7
Breast
174-175, 2330
27 688
43.8
30.1
38.8
4.2
4.29
87.8
Uterus (incl. CIS)
179-182, 2331
17 975
28.5
19.8
25.5
8.9
3.85
84.0
Uterus (only invasive)
179-182
12 733
20.3
13.1
17.1
11.2
2.73
80.7
Cervix uteri
180
7728
12.3
8.1
10.6
6.1
3.94
86.7
Corpus uteri
182
4220
6.6
4.4
5.7
5.3
5.74
89.5
Ovary
183
5396
8.6
5.7
7.2
21.0
1.54
64.9
Bladder
188
2510
4.2
1.9
2.8
15.8
2.47
73.2
Kidney
189
2431
4.0
2.0
2.8
18.4
2.21
59.7
Brain and nervous system
191-192
1706
2.9
2.0
2.3
22.9
3.31
57.1
Thyroid
193
6846
10.9
7.7
9.7
2.5
9.72
88.3
Malignant lymphoma
200-202
3839
6.2
3.6
4.8
20.4
1.71
75.5
Multiple myeloma
203
1205
2.0
0.9
1.4
36.9
1.11
46.2
Hematopoietic tissue
204-208
2540
4.1
3.1
3.5
30.8
1.08
48.5
ICD-9th, International Classification of Diseases, 9th Revision; DCO/I, proportion of cases with the death certificate only; I/D, incidence/mortality, HV/I, proportion of histologically verified cases to incident cases. *Per 100 000 population.
Incidence, completeness of reporting and accuracy of diagnosis in Japan according to sex and primary site, 1993
Sex
Primary sites
ICD-9th
No. of incidences
Crude rate*
Age-standardized rate*
Completeness of reporting
Accuracy of diagnosis
World population
Japanese 1985 model population
DCO/I (%)
I/D
HV/I (%)
Male
All sites
140-208
245878
405.2
262.0
367.0
16.1
1.73
68.6
Lip, oral cavity, pharynx
140-149
4458
7.2
4.9
6.6
9.8
1.97
83.7
Esophagus
150
9254
15.1
9.8
13.6
12.7
1.37
79.2
Stomach
151
63404
105.8
67.1
94.5
12.1
2.11
81.9
Colon
153
28897
46.8
30.7
42.8
9.1
3.14
83.1
Rectum
154
15527
25.6
16.7
22.9
8.9
2.54
85.2
Liver
155
23931
38.3
25.8
34.8
26.4
1.23
27.7
Gallbladder
156
6710
11.4
6.9
10.2
24.3
1.16
44.9
Pancreas
157
8817
14.8
9.1
13.2
28.2
1.08
32.7
Larynx
161
2921
4.8
3.1
4.3
5.6
3.65
87.4
Lung
162
35601
59.2
36.5
53.5
23.3
1.17
54.6
Skin
172 173
2930
4.8
3.1
4.4
5.2
7.88
88.6
Prostate
185
9941
16.4
9.7
15.3
13.3
2.33
75.8
Bladder
188
7880
13.0
8.1
11.8
8.3
3.55
86.3
Kidney
189
5245
8.6
5.7
7.8
12.9
2.26
72.5
Brain and nervous system
191-192
1520
2.5
2.1
2.4
21.0
2.23
68.0
Thyroid
193
968
1.6
1.1
1.5
10.2
3.45
79.7
Malignant lymphoma
200-202
5428
9.0
6.2
8.2
16.7
1.64
77.1
Multiple myeloma
203
1315
2.2
1.4
2.0
32.7
1.11
50.8
Hematopoietic tissue
204-208
3355
5.5
4.4
5.3
27.5
1.00
50.5
Female
All sites (incl. CIS)
140-208 233
184420
293.3
166.5
224.6
15.1
1.97
70.6
All sites
140-208
179022
284.9
159.5
216.0
15.4
1.91
70.0
Lip, oral cavity, pharynx
140-149
2338
3.7
2.1
2.8
9.5
2.61
82.7
Esophagus
150
1913
3.0
1.4
2.1
16.9
1.46
75.0
Stomach
151
33478
54.1
27.9
39.1
14.0
1.93
79.5
Colon
153
21593
34.2
17.8
24.9
12.8
2.43
78.3
Rectum
154
9724
15.6
8.3
11.5
10.6
2.53
82.1
Liver
155
8957
13.9
7.1
10.0
29.9
1.25
25.9
Gallbladder
156
8462
14.0
6.0
8.9
29.1
1.13
38.0
Pancreas
157
6852
11.1
5.0
7.3
32.6
1.04
25.8
Larynx
161
103
0.2
0.1
0.1
17.6
1.85
79.4
Lung
162
13085
20.8
10.1
14.5
25.5
1.18
50.9
Skin
172 173
2926
4.7
2.2
3.2
5.1
8.48
86.1
Breast
174-175 2330
27563
43.2
29.3
37.9
4.6
4.08
88.0
Uterus (incl. CIS)
179-182 2331
17498
27.3
19.4
24.8
6.7
3.94
85.3
Uterus (only invasive)
179-182
12469
19.5
12.7
16.6
8.6
2.81
82.5
Cervix uteri
180
7341
11.5
7.7
10.0
4.9
3.84
86.4
Corpus uteri
182
3508
5.5
3.6
4.7
4.9
5.08
89.8
Ovary
183
5339
8.4
5.7
7.2
18.7
1.52
66.8
Bladder
188
2705
4.3
2.0
2.9
13.5
2.55
74.5
Kidney
189
2559
4.1
2.1
3.0
16.3
2.20
65.9
Brain and nervous system
191-192
1037
1.7
1.2
1.4
22.5
2.31
60.0
Thyroid
193
4882
7.7
5.3
6.7
4.5
6.99
85.5
Malignant lymphoma
200-202
4133
6.5
3.7
5.0
16.8
1.77
78.1
Multiple myeloma
203
1290
2.1
0.9
1.4
30.1
1.12
49.4
Hematopoietic tissue
204-208
2883
4.6
3.5
3.9
26.4
1.17
50.2
ICD-9th, International Classification of Diseases, 9th Revision; DCO/I, proportion of cases with the death certificate only; I/D, incidence/mortality; HV/I, proportion of histologically verified cases to incident cases. *Per 100 000 population.
CiteULike 
Connotea 
Del.icio.us What's this?
